-
2024Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting., J Exp Med 2024 Oct; 221(10): .
-
2024Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1., Nat Immunol 2024 Sep; 25(9): 1555-1564.
-
2023SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1., Emerg Microbes Infect 2023 Dec; 12(2): 2245921.
-
2023Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups., J Gen Virol 2023 Nov; 104(11): .
-
2023Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants., Genome Res 2023 Mar; 33(3): 299-313.
-
2023Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
-
2022The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants., J Virol 2022 Oct; 96(19): e0130122.
-
2022A close shave: How SARS-CoV-2 induces the loss of cilia., J Cell Biol 2022 Jul; 221(7): .
-
2022Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine., J Virol 2022 04; 96(7): e0216121.
-
2022Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
-
2022BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2., Nat Cell Biol 2022 01; 24(1): 24-34.
-
2021SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation., EMBO J 2021 12; 40(24): e108944.
-
2021Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential., Nat Commun 2021 09; 12(1): 5553.
-
2021SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance., Nat Commun 2021 Jul; 12(1): 4354.
-
2021Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination., PLoS Pathog 2021 06; 17(6): e1009647.
-
2021Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions., Int J Mol Sci 2021 Jan; 22(2): .
-
2020Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection., Sci Adv 2020 02; 6(8): eaaz0374.
-
2019A role for antibodies in natural HIV control, Curr Opin HIV AIDS 2019 Apr;.
-
2018CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
-
2018CD4 T cell-mediated HLA class II cross-restriction in HIV controllers, Sci Immunol 2018 06;3(24).
-
2018A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers, MBio 2018 May;9(3).
-
2017DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers, J. Immunol. 2017 Nov;199(10):3437-3452.
-
2016Public T cell receptors confer high-avidity CD4 responses to HIV controllers, J. Clin. Invest. 2016 Apr;.
-
2016TCR clonotypes: molecular determinants of T-cell efficacy against HIV, Curr Opin Virol 2016 Feb;16:77-85.
-
2015[IRIS: a paradoxical inflammatory reaction in patients treated simultaneously for tuberculosis and HIV], Med Sci (Paris) 2015 Jan;31(1):53-9.
-
2014Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS 2014 Jul;28(11):1593-602.
-
2013Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles, J. Virol. 2013 Sep;87(18):10368-80.
-
2013Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia, PLoS ONE 2013;8(1):e55570.
-
2012HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term, J. Virol. 2012 Oct;86(19):10661-74.
-
2011HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization, AIDS 2011 Sep;25(15):1843-53.
-
2011HIV controllers: a multifactorial phenotype of spontaneous viral suppression, Clin. Immunol. 2011 Oct;141(1):15-30.
-
2011CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory, PLoS ONE 2011;6(4):e18726.
-
2011[Role of CD4 lymphocytes in the efficient immune response of HIV controllers], Bull. Acad. Natl. Med. 2011 Mar;195(3):545-57; discussion 557-9.
-
2010Immune mechanisms of HIV control, Curr. Opin. Immunol. 2010 Aug;22(4):488-96.
-
2010HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity, PLoS Pathog. 2010 Feb;6(2):e1000780.
-
2010Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway, J. Virol. 2010 Jan;84(1):96-108.
-
2009Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4, Blood 2010 May;115(18):3708-17.
-
2009HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression, AIDS 2009 Jun;23(10):1197-207.
-
2009A programmed switch from IL-15- to IL-2-dependent activation in human NK cells, J. Immunol. 2009 May;182(10):6267-77.
-
2007Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study, J. Virol. 2007 Dec;81(24):13904-15.
-
2007Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure, Virology 2007 Oct;367(1):196-211.
-
2006Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks, Retrovirology 2006;3:81.
-
2004CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes, J. Immunol. 2004 Dec;173(12):7150-60.
-
2004The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression, Front. Biosci. 2004 Jan;9:521-39.
-
2003A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication, J. Virol. 2003 Jan;77(2):1245-56.
-
2002Interaction of HIV-1 integrase with DNA repair protein hRad18, J. Biol. Chem. 2002 Jul;277(30):27489-93.
-
2002Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones, J. Virol. 2002 Feb;76(4):1588-99.
-
2001A divergent simian immunodeficiency virus from sooty mangabey with an atypical Tat-TAR structure, AIDS Res. Hum. Retroviruses 2001 Aug;17(12):1155-65.
-
2000Age-dependent changes in T cell homeostasis and SIV load in sooty mangabeys, J. Med. Primatol. 2000 Aug;29(3-4):158-65.
-
2000Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection, J. Virol. 2000 Feb;74(3):1209-23.
-
1998Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease, J. Virol. 1998 May;72(5):3872-86.
-
1996Interferon-gamma expression in macaque lymph nodes during primary infection with simian immunodeficiency virus, Cytokine 1996 Nov;8(11):844-52.
-
1996The relationship between the interferon alpha response and viral burden in primary SIV infection, AIDS Res. Hum. Retroviruses 1996 Sep;12(13):1273-8.
-
1996Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection, Res. Virol. 1996 Mar-Jun;147(2-3):181-9.
-
1995Low susceptibility of resident microglia to simian immunodeficiency virus replication during the early stages of infection, Neuropathol. Appl. Neurobiol. 1995 Dec;21(6):535-9.
-
1995Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus, Virology 1995 Nov;213(2):535-48.
-
1995Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge, AIDS Res. Hum. Retroviruses 1995 Nov;11(11):1397-406.
-
1994Early stages of feline immunodeficiency virus infection in lymph nodes and spleen, AIDS Res. Hum. Retroviruses 1994 Dec;10(12):1731-8.
-
1994Cytokine patterns in lymph nodes during the early stages of simian immunodeficiency virus infection, Res. Immunol. 1994 Oct-Dec;145(8-9):702-5.
-
1994Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression, J. Virol. 1994 Oct;68(10):6634-43.
-
1994Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells, Am. J. Pathol. 1994 Jun;144(6):1226-37.
-
1994Early events in lymph nodes during infection with SIV and FIV, Res. Virol. 1994 May-Aug;145(3-4):221-7.
-
1994Kinetics of primary SIV infection in lymph nodes, J. Med. Primatol. 1994 Feb-May;23(2-3):117-24.
-
1993Target cells during early SIV encephalopathy, Res. Virol. 1993 Jan-Feb;144(1):41-6.
-
1992Comparison of early and late feline immunodeficiency virus encephalopathies, AIDS 1992 Apr;6(4):399-406.
-
1991Early viral replication in the brain of SIV-infected rhesus monkeys, Am. J. Pathol. 1991 Dec;139(6):1273-80.
-
1991Early SIV encephalopathy, J. Med. Primatol. 1991 Jun;20(4):159-66.
-
1989The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity, J. Virol. 1989 Oct;63(10):4395-403.
-
1987Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses, Nature 1987 Aug 6-12;328(6130):543-7.